As of December 2024 Neuren Pharmaceuticals has a market cap of A$1.57 Billion. This makes Neuren Pharmaceuticals the world's 5549th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.